Blocking TNF-α by a monoclonal antibody effectively inhibits tumor growth, increases tumor immunity, and decreases the member of CAMs-M2 in murine CRC cells-transplanted mouse model [170]. The gene discussed is TNF; the disease is colorectal carcinoma.